突发！000788，董事长被刑拘！

Core Viewpoint - The chairman and president of Beijing University Pharmaceutical, Xu Xiren, has been criminally detained, affecting his ability to perform duties, while the company has appointed other executives to take over his responsibilities [1][4]. Group 1: Company Announcement - On October 25, the company announced that Xu Xiren temporarily could not perform his duties due to personal reasons and authorized Chen Yuezhong to act as chairman and Yu Mengchuan as president [4]. - The authorization is effective from the date of signing until Xu Xiren provides written notice to terminate it [4]. - The company has assured that its governance structure and internal control mechanisms are intact, and operations remain normal despite the leadership change [4]. Group 2: Company Background - Beijing University Pharmaceutical was established in 1965 and listed on the Shenzhen Stock Exchange in 1997 [5]. - The company became a member of the Ping An Group in 2022 and is controlled by Xu Xiren [5]. - The company focuses on drug research, production, and sales, with a portfolio of 166 drug approvals and 13 first-generic drug approvals [5]. Group 3: Financial Performance - In the first half of the year, the company reported total revenue of 957 million yuan, a decrease of 5.04% year-on-year, while net profit increased by 15.51% to 100 million yuan [6].